An ultra-modern Higher Education Centre of Excellence (ACE) was officially inaugurated on Friday, November 8, at the ...

The topline data showed ISM001-055 to have improved the forced vital capacity (FVC) of IPF patients studied 12 weeks after ...

The firms said that the deal will provide access to Tempus' testing menu for healthcare providers at 800 cancer care locations that use Flatiron's OncoEMR platform.

Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...

Trace Neuroscience aims to advance an RNA-binding therapy designed to preserve — and potentially improve — muscle function in ...

University of Wisconsin-Madison researchers targeting a group of hereditary neurodegenerative diseases have found success ...

Some American clinics claim they can ‘rank’ embryos for IVF using a genetic screening system which is illegal in the UK ...

In recent years, scientists have created a range of new methods based on CRISPR-Cas technology for precisely editing the ...

A cutting-edge genetic test can rapidly detect and identify almost any kind of disease-causing ... eventually fell into a ...

Relief Therapeutics announces positive final results of RLF-TD011 trial in epidermolysis bullosa: Geneva Tuesday, November 12, 2024, 10:00 Hrs [IST] Relief Therapeutics Holding SA ...

Genetic-testing lab 23andMe plans to cut its workforce by 40% and end its therapeutics program in an effort to cut costs, the ...

Researchers at Washington University have discovered a new genetic disorder affecting protein folding, offering potential new treatment avenues for rare brain conditions. When most people feeling ...